Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BloomWell Rx vs Breeze Meds

By GLP-1 ScorecardUpdated

BloomWell Rx
Site position #335

Lower grade

Breeze Meds
Site position #90

Higher grade

Score comparison

Breeze Meds has the higher recorded score — 72.4/100 to 61.3/100.

Breeze Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Charges nothing until a provider approves you — but keeps its pricing inside the intake.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBreeze Meds +18
54
72
Dose & formulationBreeze Meds +2
64
66
Clinical oversightBreeze Meds +5
71
76
Labs & monitoringBreeze Meds +7
53
60
FulfillmentBreeze Meds +14
70
84
Contract termsBreeze Meds +31
55
86
BloomWell Rx · top barBreeze Meds · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricBloomWell RxBreeze Meds
WeighScore61.3/10072.4/100
GradeCC
Site position#335#90
Semaglutide$199/mo (starting dose, compounded)From $199/mo
Tirzepatide$249/mo (starting dose, compounded)From $299/mo first month, $399/mo thereafter
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
BloomWell Rx

Site position #335 · C

Strengths

  • Transparent pricing — compounded semaglutide from $199/mo, tirzepatide (GLP-1/GIP) from $249/mo
  • Free initial visit; fully online process with flexible dosing options
  • Discloses meds are compounded by a licensed third-party pharmacy; also offers NAD+, sermorelin, glutathione
  • Full legal suite published (Terms, Privacy, HIPAA Notice, Returns & Refunds)

What to consider

  • 'Starts at' pricing — final cost depends on dose and plan
  • Compounding pharmacy partner not named ('licensed third-party pharmacy')
  • LegitScript certification was not documented on the public pages reviewed
  • Operating medical entity not clearly named (site operated by a marketing agency)
Breeze Meds

Site position #90 · C

Strengths

  • Nothing charged until a provider approves you, and the consult is free if you go ahead
  • One inclusive price covering consult, medication, supplies, shipping and support
  • LegitScript certified, all 50 states, cancel or change plan at any time
  • NAD+ injections offered alongside the GLP-1 line

What to consider

  • The public site names no molecule behind its "from $199" — tirzepatide pricing appears only inside the intake
  • Every quoted figure is for the LOWEST dose; the funnel says higher doses may cost more
  • An $80 consultation fee applies if you are approved and then decline
  • Injection only, compounded only, with no published lab program

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard